跳到正文
原文
Endpoints News· @endpts · X·· 7 天前AI 评分40
AI 导读

礼来投资的Oyster Therapeutics融资6000万美元,开发可摧毁tau蛋白致病形式的药片,tau是一种与阿尔茨海默病相关的大脑蛋白。https://endpoints.news/london-startup-raises-60m-for-degraders-aimed-at-alzheimers-protein-tau/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial

正文

Lilly-backed Oyster Therapeutics raised $60M to develop pills that destroy pathogenic forms of tau, a brain protein implicated in Alzheimer's. https://endpoints.news/london-startup-raises-60m-for-degraders-aimed-at-alzheimers-protein-tau/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial

来源:Endpoints News · x.com